Evaluation of clinical and laboratory aspects in adolescents with sickle cell anemia, before and after treatment with hydroxyurea
International Journal of Development Research
Evaluation of clinical and laboratory aspects in adolescents with sickle cell anemia, before and after treatment with hydroxyurea
Received 10th June, 2022 Received in revised form 16th June, 2022 Accepted 20th July, 2022 Published online 22nd August, 2022
Copyright © 2022, Agleison Ramos Omido Junior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective: To evaluate clinical and laboratory aspects of adolescents with Sickle Cell Disease treated with hydroxyurea. Methodology: a retrospective cohort study of patients with sickle cell anemia. The population will be adolescents who have been on hydroxyurea treatment for at least 2 years. Patients with other hemoglobinopathies, who abandoned treatment or died will be excluded. Data will be collected from medical records from September to October 2022. All ethical and legal principles will be respected and a significance level of 5% (p<0.05) will be considered.
